Drug Target Review2026-03-26T11:25:00
University of Colorado Anschutz Cancer Center scientists have uncovered how metastatic breast cancer cells exploit pulmonary repair pathways to establish tumours in the lungs.
Breast cancer is often treatable in its early stages, but once it spreads to the lungs, options become limited. Now, researchers have discovered how tumour cells hijack the lung’s natural repair system to fuel their own growth — and found that an existing drug could slow the process.
This breakthrough could lead to new ways of treating metastatic breast cancer, targeting not just the cancer cells themselves but the environment that allows them to thrive.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-23T06:20:00
Contributor Laura Lotfi, Drug Target Review
2026-06-15T07:00:00
Contributor Professor Dipak Ramji, Drug Target Review
2026-08-04T08:39:00
Author Paul Michaels
2026-10-07T14:00:00
Sponsored by WuXi AppTec
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2023-03-23T14:46:21
Sponsored by Bio-Techne
Site powered by Webvision Cloud